DrugPatentWatch Database Preview
Mylan Asi Company Profile
What is the competitive landscape for MYLAN ASI, and what generic and branded alternatives to MYLAN ASI drugs are available?
MYLAN ASI has eighteen approved drugs.
Summary for Mylan Asi
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 14 |
| NDAs: | 18 |
Drugs and US Patents for Mylan Asi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Asi | SUMATRIPTAN SUCCINATE | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 090641-001 | Jul 28, 2010 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Asi | AZITHROMYCIN | azithromycin | INJECTABLE;INJECTION | 065506-001 | Mar 24, 2009 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Asi | LORAZEPAM | lorazepam | INJECTABLE;INJECTION | 200542-002 | Apr 28, 2017 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mylan Asi | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 090318-004 | Sep 23, 2014 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Asi | BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 091487-002 | Oct 18, 2011 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Asi | BACITRACIN | bacitracin | INJECTABLE;INJECTION | 090211-001 | May 11, 2010 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
